warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
BMS CA209800: Phase II, Randomized, Study of Multiple Administration Regimens for Nivolumab plus Ipilimumab in Subjects with Renal Cell Carcinoma
Brief Description  
Incidence of adverse events (AEs) in anaphylactic reaction SMQ (Standard Medical Dictionary for Regulatory Activities Queries).
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Kidney
Status  
OPEN
Start Date  
04/21/2017
IRB Number  
00020828
Principal Investigator  
Amin, Asim
Contact Name  
Gretchen Lee Nobis

For More Information, Contact  Gretchen  Lee, Nobis
Phone:  980-442-2305 Fax:    
Email:  gretchen.nobis@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close